These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10027793)

  • 21. Premercapturic acid metabolites of bromobenzene derived via its 2,3- and 3,4-oxide metabolites.
    Zheng J; Hanzlik RP
    Xenobiotica; 1991 Apr; 21(4):535-46. PubMed ID: 1897252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic bromobenzene epoxidation and binding: prevention by ascorbyl palmitate.
    Zannoni VG; Marker EK; Lau SS
    Drug Nutr Interact; 1982; 1(3):193-204. PubMed ID: 6926828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A proteomic analysis of bromobenzene reactive metabolite targets in rat liver cytosol in vivo.
    Koen YM; Gogichaeva NV; Alterman MA; Hanzlik RP
    Chem Res Toxicol; 2007 Mar; 20(3):511-9. PubMed ID: 17305373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of hyperthyroidism on the in vitro metabolism and covalent binding of 1,1-dichloroethylene in rat liver microsomes.
    Gunasena GH; Kanz MF
    J Toxicol Environ Health; 1997 Oct; 52(2):169-88. PubMed ID: 9310148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposite behaviors of reactive metabolites of tienilic acid and its isomer toward liver proteins: use of specific anti-tienilic acid-protein adduct antibodies and the possible relationship with different hepatotoxic effects of the two compounds.
    Bonierbale E; Valadon P; Pons C; Desfosses B; Dansette PM; Mansuy D
    Chem Res Toxicol; 1999 Mar; 12(3):286-96. PubMed ID: 10077492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol.
    Gardner I; Bergin P; Stening P; Kenna JG; Caldwell J
    Chem Res Toxicol; 1996 Jun; 9(4):713-21. PubMed ID: 8831815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bromobenzene metabolism in vivo and in vitro. The mechanism of 4-bromocatechol formation.
    Miller NE; Thomas D; Billings RE
    Drug Metab Dispos; 1990; 18(3):304-8. PubMed ID: 1974190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isozyme-selective metabolism of ethyl carbamate by cytochrome P450 (CYP2E1) and carboxylesterase (hydrolase A) enzymes in murine liver microsomes.
    Lee RP; Parkinson A; Forkert PG
    Drug Metab Dispos; 1998 Jan; 26(1):60-5. PubMed ID: 9443854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production and characterization of specific antibodies: utilization to predict organ- and species-selective pneumotoxicity of 3-methylindole.
    Kaster JK; Yost GS
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):324-37. PubMed ID: 9144449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of antibodies to Di- and trichloroacetylated proteins and immunochemical detection of protein adducts in rats treated with perchloroethene.
    Pähler A; Birner G; Parker J; Dekant W
    Chem Res Toxicol; 1998 Sep; 11(9):995-1004. PubMed ID: 9760273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
    Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Halothane metabolism: immunochemical evidence for molecular mimicry of trifluoroacetylated liver protein adducts by constitutive polypeptides.
    Christen U; Bürgin M; Gut J
    Mol Pharmacol; 1991 Sep; 40(3):390-400. PubMed ID: 1716732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of human and mouse liver microsomal metabolism of bromobenzene and chlorobenzene to 2- and 4-halophenols.
    Kerger BD; Roberts SM; James RC
    Drug Metab Dispos; 1988; 16(5):672-7. PubMed ID: 2906588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of a new antibacterial peptide S-thanatin in rat plasma by an indirected-ELISA.
    Wu G; Wang S; Wang X; Li X; Deng X; Shen Z; Xi T
    Peptides; 2011 Jul; 32(7):1484-7. PubMed ID: 21605610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bromobenzene epoxidation leading to binding on macromolecular protein sites.
    Lau SS; Zannoni VG
    J Pharmacol Exp Ther; 1981 Nov; 219(2):563-72. PubMed ID: 7288634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-reactive metabolites of carbamazepine in mouse liver microsomes.
    Lillibridge JH; Amore BM; Slattery JT; Kalhorn TF; Nelson SD; Finnell RH; Bennett GD
    Drug Metab Dispos; 1996 May; 24(5):509-14. PubMed ID: 8723729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation and detoxification of bromobenzene in extrahepatic tissues.
    Monks TJ; Lau SS
    Life Sci; 1984 Jul; 35(5):561-8. PubMed ID: 6748863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and pharmacological characterization of microsomal human liver flumazenil carboxylesterase.
    Kleingeist B; Böcker R; Geisslinger G; Brugger R
    J Pharm Pharm Sci; 1998; 1(1):38-46. PubMed ID: 10942971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative studies of the in vitro metabolism and covalent binding of 14C-benzene by liver slices and microsomal fraction of mouse, rat, and human.
    Brodfuehrer JI; Chapman DE; Wilke TJ; Powis G
    Drug Metab Dispos; 1990; 18(1):20-7. PubMed ID: 1970773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The covalent binding of bromobenzene with nucleic acids.
    Colacci A; Arfellini G; Mazzullo M; Prodi G; Grilli S
    Toxicol Pathol; 1985; 13(4):276-82. PubMed ID: 2422722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.